Clinical trial

BostonGene and Exigent Genomic INsight Study

NCT06272864

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2024-04-08

PhaseN/A

Study timeline

Study start (actual)2024-04-08Date precision: day

Registry last updated2025-02-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerverified · MONDO: breast cancer

Non-small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Melanomaverified · MONDO: melanoma

Sarcomaverified · MONDO: sarcoma

Interventions

Sponsors & collaborators

BostonGenelead sponsor

Exigentcollaborator

Mapped research locations

HoustonTexas, United States1 AlbuquerqueNew Mexico, United States1 TulsaOklahoma, United States1 Fort WayneIndiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06272864 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.